Cosmetics Europe Says EU’s ‘Radical’ Regulatory Drift Sends Concerning Signal To World
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?
In this episode, HBW Insight chats with Louise Witter, director and principal consultant at UK-based Chemical Legislation Professionals, about proposed revisions to the EU’s Classification, Labeling and Packaging Regulation (CLP) to introduce new hazard classes, including for endocrine disruptors. The discussion, just prior to the Commission’s adoption of the proposal on 19 December, ranges from implications for cosmetics companies to reflections on the EU Green Deal, which may be outpacing scientific consensus and endangering an already beleaguered and highly regulated chemicals industry.
Cosmetics Europe Says EU’s ‘Radical’ Regulatory Drift Sends Concerning Signal To World
Create an account to read this article
Already a subscriber?
Representing about a fifth of all licensed medicines in the UK, OTCs are considered a critical part of the country's health system, according to a recently published Department of Health and Social Care (DHSC) paper on UK medicines supply issues.
Children and young adults will in future learn more about responsible self-care, including when it is appropriate to see a pharmacist, specific instructions for dental health and information about health risks associated with smoking, vaping, and other nicotine products such as nicotine pouches.
HBW Insight speaks to Haleon's UK & Ireland general manager Jo Cooper about how she plans to translate the firm's ambitious global growth strategy to a local context.
Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.
Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.
Concerns raised by two recent studies prompt UK researchers to argue for greater regulation with regards to direct-to-consumer test kits.
AESGP has formally submitted a request to the General Court of the European Union to intervene in the European Federation of Pharmaceutical Industries and Association’s legal action against the revised EU Urban Wastewater Directive.